Joseph Baroldi

CIK: 0001813775

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)20 (40.8%)

Position reduction

Option Exercises (M)18 (36.7%)

Derivative conversions

Awards (A)11 (22.4%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

IONS

IONIS PHARMACEUTICALS INC

Officer

Discretionary Trading P&L

Holdings

Transaction History (49 total)

IONS
IONIS PHARMACEUTICALS INC
Jun 26, 2026
Exercise(M)
Indirect
3.9K shares at avg. $56.78$220K
IONS
IONIS PHARMACEUTICALS INC
Jun 26, 2026
Sale(S)
Indirect
5.6K shares at avg. $80.16$452K
IONS
IONIS PHARMACEUTICALS INC
Jun 26, 2026
Exercise(M)
Indirect
1.8K shares at avg. $32.60$58K
IONS
IONIS PHARMACEUTICALS INC
Apr 28, 2026
Sale(S)
Direct
1.6K shares at avg. $71.79$117K
IONS
IONIS PHARMACEUTICALS INC
Apr 16, 2026
Sale(S)
Direct
5.6K shares at avg. $74.56$419K
IONS
IONIS PHARMACEUTICALS INC
Apr 15, 2026
Exercise(M)
Direct
10.8K shares-
IONS
IONIS PHARMACEUTICALS INC
Mar 4, 2026
Sale(S)
Indirect
201 shares at avg. $80.00$16K
IONS
IONIS PHARMACEUTICALS INC
Mar 4, 2026
Exercise(M)
Indirect
238 shares at avg. $56.78$14K
IONS
IONIS PHARMACEUTICALS INC
Mar 4, 2026
Sale(S)
Indirect
238 shares at avg. $80.00$19K
IONS
IONIS PHARMACEUTICALS INC
Mar 4, 2026
Exercise(M)
Indirect
201 shares at avg. $32.60$7K
IONS
IONIS PHARMACEUTICALS INC
Mar 3, 2026
Exercise(M)
Indirect
879 shares at avg. $32.60$29K
IONS
IONIS PHARMACEUTICALS INC
Mar 3, 2026
Sale(S)
Indirect
36 shares at avg. $81.01$3K
IONS
IONIS PHARMACEUTICALS INC
Mar 3, 2026
Sale(S)
Direct
4.1K shares at avg. $79.36$325K
IONS
IONIS PHARMACEUTICALS INC
Mar 3, 2026
Exercise(M)
Indirect
820 shares at avg. $56.78$47K
IONS
IONIS PHARMACEUTICALS INC
Mar 3, 2026
Sale(S)
Indirect
2.1K shares at avg. $80.41$168K
IONS
IONIS PHARMACEUTICALS INC
Jan 30, 2026
Sale(S)
Direct
5.3K shares at avg. $82.96$439K
IONS
IONIS PHARMACEUTICALS INC
Jan 29, 2026
Award(A)
Direct
10.3K shares-
IONS
IONIS PHARMACEUTICALS INC
Jan 16, 2026
Sale(S)
Direct
6.9K shares at avg. $75.75$523K
IONS
IONIS PHARMACEUTICALS INC
Jan 16, 2026
Sale(S)
Indirect
1.1K shares at avg. $75.78$87K
IONS
IONIS PHARMACEUTICALS INC
Jan 15, 2026
Exercise(M)
Indirect
2.9K shares-
IONS
IONIS PHARMACEUTICALS INC
Jan 15, 2026
Exercise(M)
Direct
17K shares-
IONS
IONIS PHARMACEUTICALS INC
Jan 15, 2026
Award(A)
Performance Restricted Stock Units
Direct
25.8K shares-
IONS
IONIS PHARMACEUTICALS INC
Jan 15, 2026
Award(A)
Restricted Stock Unit
Direct
9.7K shares-
IONS
IONIS PHARMACEUTICALS INC
Jan 15, 2026
Award(A)
Restricted Stock Unit
Indirect
3.9K shares-
IONS
IONIS PHARMACEUTICALS INC
Jan 2, 2026
Award(A)
Non-Qualified Stock Option (right to buy)
Indirect
2.6K shares-

		Type	Shares	Price		Ownership
Jun 26, 2026	IONS IONIS PHARMACEUTICALS INC	Exercise(M)	3,866	$56.78	$219,511	Indirect
Jun 26, 2026	IONS IONIS PHARMACEUTICALS INC	Sale(S)	5,635	$80.16	$451,699	Indirect
Jun 26, 2026	IONS IONIS PHARMACEUTICALS INC	Exercise(M)	1,769	$32.60	$57,669	Indirect
Apr 28, 2026	IONS IONIS PHARMACEUTICALS INC	Sale(S)	1,626	$71.79	$116,727	Direct
Apr 16, 2026	IONS IONIS PHARMACEUTICALS INC	Sale(S)	5,619	$74.56	$418,953	Direct
Apr 15, 2026	IONS IONIS PHARMACEUTICALS INC	Exercise(M)	10,837	-	$0	Direct
Mar 4, 2026	IONS IONIS PHARMACEUTICALS INC	Sale(S)	201	$80.00	$16,080	Indirect
Mar 4, 2026	IONS IONIS PHARMACEUTICALS INC	Exercise(M)	238	$56.78	$13,514	Indirect
Mar 4, 2026	IONS IONIS PHARMACEUTICALS INC	Sale(S)	238	$80.00	$19,040	Indirect
Mar 4, 2026	IONS IONIS PHARMACEUTICALS INC	Exercise(M)	201	$32.60	$6,553	Indirect
Mar 3, 2026	IONS IONIS PHARMACEUTICALS INC	Exercise(M)	879	$32.60	$28,655	Indirect
Mar 3, 2026	IONS IONIS PHARMACEUTICALS INC	Sale(S)	36	$81.01	$2,916	Indirect
Mar 3, 2026	IONS IONIS PHARMACEUTICALS INC	Sale(S)	4,096	$79.36	$325,059	Direct
Mar 3, 2026	IONS IONIS PHARMACEUTICALS INC	Exercise(M)	820	$56.78	$46,560	Indirect
Mar 3, 2026	IONS IONIS PHARMACEUTICALS INC	Sale(S)	2,088	$80.41	$167,892	Indirect
Jan 30, 2026	IONS IONIS PHARMACEUTICALS INC	Sale(S)	5,296	$82.96	$439,364	Direct
Jan 29, 2026	IONS IONIS PHARMACEUTICALS INC	Award(A)	10,278	-	$0	Direct
Jan 16, 2026	IONS IONIS PHARMACEUTICALS INC	Sale(S)	6,907	$75.75	$523,205	Direct
Jan 16, 2026	IONS IONIS PHARMACEUTICALS INC	Sale(S)	1,149	$75.78	$87,071	Indirect
Jan 15, 2026	IONS IONIS PHARMACEUTICALS INC	Exercise(M)	2,850	-	$0	Indirect
Jan 15, 2026	IONS IONIS PHARMACEUTICALS INC	Exercise(M)	17,037	-	$0	Direct
Jan 15, 2026	IONS IONIS PHARMACEUTICALS INC	Award(A) Performance Restricted Stock Units	25,800	-	-	Direct
Jan 15, 2026	IONS IONIS PHARMACEUTICALS INC	Award(A) Restricted Stock Unit	9,675	-	-	Direct
Jan 15, 2026	IONS IONIS PHARMACEUTICALS INC	Award(A) Restricted Stock Unit	3,900	-	-	Indirect
Jan 2, 2026	IONS IONIS PHARMACEUTICALS INC	Award(A) Non-Qualified Stock Option (right to buy)	2,600	-	-	Indirect

1-25 of 49 transactions

About Baroldi Joseph

Baroldi Joseph (SEC CIK 0001813775) files insider reports with the SEC as EVP, Chief Business Officer of IONIS PHARMACEUTICALS INC (IONS).

Signal8 holds 15 ownership filings by Baroldi Joseph, all Form 4s, filed between Jan 6, 2025 and Jun 30, 2026. Those filings report 49 transactions, from Jan 2, 2025 to Jun 26, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Baroldi Joseph's filings is in CARLSBAD, CA.

Recent filings by Baroldi Joseph

Jun 26, 2026: Option exercise of IONS shares (Form 4, code M).
Jun 26, 2026: Open-market sale of IONS shares (Form 4, code S).
Jun 26, 2026: Option exercise of IONS shares (Form 4, code M).
Apr 28, 2026: Open-market sale of IONS shares (Form 4, code S).
Apr 16, 2026: Open-market sale of IONS shares (Form 4, code S).

Other insiders filing for IONIS PHARMACEUTICALS INC (IONS)

Devers Shannon L., EVP, Chief Human Resources Ofc
Swayze Eric, EVP Research
BENNETT C FRANK, EVP, Chief Scientific Officer
O'NEIL PATRICK R., EVP CLO & General Counsel
Monia Brett P, Chief Executive Officer
Birchler Brian, EVP, Corp and Development Ops

How to read Form 4 transaction codes